A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty

December 14, 2022 updated by: University of Aarhus

A Comparison of Two Different Surgical Techniques to Preserve the Bony Supply and Improve Implant Longevity in Hip Resurfacing Arthroplasty

The purpose of the study is to compare two different surgical techniques in hip resurfacing arthroplasty (RHA), comparing bloodflow and metabolism in the femoral head, as well as implant migration, periprosthetic bone mineral density, gait function and patient recovery.

Study Overview

Detailed Description

BACKGROUND:

6700 total hip replacements are performed each year in Denmark due to osteoarthritis. Young patients sustain a substantial risk of early implant failure due to high-activity daily living, and among patients younger than 55 years at surgery 20 percent need revision surgery within ten years. Revision surgery is more complicated than primary surgery and associated with decreased implant longevity due to decreased bone stock. Resurfacing hip arthroplasty (RHA), restores the anatomy of the hip as only the articulating joint surfaces are replaced, and thus more bone is left to ensure a better opportunity of successful revision surgery later on. The clinical midterm evaluation of RHA survival is promising, but two major complications leading to early revision, namely osteonecrosis and femoral neck fracture, has raised concern regarding the influence of surgical technique on the vascularity of the femoral head. RHA is commonly performed through a posterolateral surgical approach. By this technique muscle tendons are spilt resulting in decreased patient mobility for several weeks after surgery, but more importantly, the blood supply is compromised as a large artery has to be ligated. This is speculated to decrease the blood supply to femoral head and neck and thereby increase the risk of osteonecrosis, femoral neck fracture, and implant failure. With a new surgical technique facilitating an anterolateral approach to the hip joint the blood supply is left intact as well as the muscle tendons.

HYPOTHESIS:

An anterolateral surgical approach in resurfacing hip arthroplasty will 1) preserve the blood supply to the femoral head and neck and improve implant longevity, and 2) spare the muscle tendons and ease patient recovery.

METHOD and FACILITIES:

50 patients, aged 30 to 60 years, with osteoarthrosis of the hip will be randomised to a RHA inserted by either an anterolateral or a posterolateral surgical approach. Primary points of evaluation are 1) blood supply to the femoral head and neck measured intraoperatively by Laser Doppler flowmetry and postoperatively by microdialysis established during surgery. Secondary points of evaluation are 1) implant fixation measured by radiostereometric analysis (RSA), and 2) periprosthetic bone mineral density (BMD) measured by dual energy x-ray absorptiometry (DEXA), 3) gait analysis and 4) clinical scores of function, pain and activities of daily living (Harris Hip Score , Visual Analogue Scale).

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Kjeld Søballe, Professor, Dr. Med, MD
  • Phone Number: +45 8949 7425
  • Email: kjeld@soballe.com

Study Locations

    • Aarhus County
      • Aarhus C, Aarhus County, Denmark, 8000
        • Aarhus University Hospital, Department of Orthopaedic Surgery, Tage-Hansens Gade 2

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary hip OA;
  • Secondary hip OA due to mild and moderate acetabular dysplasia;
  • Sufficient bone quality for cementless acetabular component;
  • Suited for resurfacing of the femoral head, pre and intraoperatively assessed;
  • Age 30 to 60 years.

Exclusion Criteria:

  • Neuromuscular or vascular diseases in affected leg;
  • Patients found intra-operatively to be unsuited for a cementless acetabular component or cementing of the femoral component;
  • Need of NSAID postoperatively;
  • Fracture sequelae;
  • Females at risk of pregnancy, no safe contraceptives;
  • Severe hip dysplasia;
  • Sequelae from hip disease in childhood;
  • Medicine with large effect on bone density, K vitamin antagonists, loop-diuretics;
  • Alcoholism, females over 14 units per week, males over 21 units per week; AVN;
  • Osteoporosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Posterior approach
Posterior surgical approach in hip resurfacing arthroplasty
two different surgical approaches in hip resurfacing arthroplasty
Other Names:
  • ReCap Hip Resurfacing System
Active Comparator: Anterolateral approach
Anterolateral surgical approach in hip resurfacing arthroplasty
two different surgical approaches in hip resurfacing arthroplasty
Other Names:
  • ReCap Hip Resurfacing System

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
femoral head blood flow, evaluated by Laser Doppler Flowmetry
Time Frame: during surgery
during surgery
femoral head metabolism, evaluated by microdialysis
Time Frame: 3 days
3 days

Secondary Outcome Measures

Outcome Measure
Time Frame
implant fixation, evaluated by RSA (radiostereogrammetric analysis)
Time Frame: postoperatively; 3 months; 1,2 and 5 years
postoperatively; 3 months; 1,2 and 5 years
periprosthetic bone mineral density, evaluated by DEXA
Time Frame: pre- and postoperatively; 1 and 2 years
pre- and postoperatively; 1 and 2 years
gait function, evaluated by gait analysis
Time Frame: preoperatively; 3 months and 1 year
preoperatively; 3 months and 1 year
patient recovery, evaluated by Harris Hip Score and Visual Analogue Scale
Time Frame: preoperatively and 3 months
preoperatively and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2008

Primary Completion (Actual)

February 20, 2017

Study Completion (Actual)

November 1, 2020

Study Registration Dates

First Submitted

June 2, 2009

First Submitted That Met QC Criteria

June 3, 2009

First Posted (Estimate)

June 4, 2009

Study Record Updates

Last Update Posted (Actual)

December 15, 2022

Last Update Submitted That Met QC Criteria

December 14, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteonecrosis

Clinical Trials on Surgical approach (ReCap Hip Resurfacing System)

3
Subscribe